Deborah Reale

Article

Mean income for ObGyns increased in 2012

Author:: Deborah Reale

Publish date: July 10, 2013

A 2013 survey reveals that overall physician salaries increased from 2011, and obstetricians and gynecologists are no exception. ObGyns reported th...

News

Native tissue is superior to vaginal mesh for prolapse repair, two studies report

Author:: Deborah Reale

Publish date: April 1, 2013

From UNC at Chapel Hill: The use of mesh for anterior prolapse is associated with long-term increased risk of any repeat surgery—especially ...

News

National initiative cuts incidence of birth hypoxia by 25%

Author:: Deborah Reale

Publish date: December 1, 2012

By reducing harm to babies and mothers, 14 participating hospitals also lowered associated liability claims and payouts

News

ObGyns’ status of Maintenance of Certification now public

Author:: Deborah Reale

Publish date: November 1, 2012

Information is now accessible via the American Board of Medical Specialties concerning whether physicians are meeting MOC requirements set by the ...

News

New molecular cervical cancer test based on TERC gene marker

Author:: Deborah Reale

Publish date: September 1, 2012

Use this new assay to verify unclear Pap and HPV testing results

News

Pregnant women taking antihypertensives—some shown to cause fetal risk—in increasing numbers

Author:: Deborah Reale

Publish date: September 1, 2012

The prevalence of high blood pressure medications use in pregnancy is almost 5%, despite a lack of data on safety and proper use of these medicati...

News

Implementation of ICD-10 codes delayed 1 year

Author:: Deborah Reale

Publish date: September 1, 2012

Codes for new procedures and diagnoses will now go into effect October 1, 2014

News

CDC: Stop using oral cephalosporins to treat gonorrhea

Author:: Deborah Reale

Publish date: September 1, 2012

Start using combination therapy with ceftriaxone and either azithromycin or doxycycline because of increasing resistance to oral cephalosporins.

News

New overactive bladder treatment approved by FDA

Author:: Deborah Reale

Publish date: August 1, 2012

Myrbetriq (mirabegron) from Astellas is the first beta-3 adrenergic agonist accepted for OAB

News

Markey commends J&J’s wisdom in ceasing to market vaginal mesh

Author:: Deborah Reale

Publish date: July 1, 2012

Congressman Markey’s ultimate goal is to thwart a dangerous loophole in the FDA medical device approval process...

News

Is there a relationship between in vitro fertilization and breast cancer?

Author:: Deborah Reale

Publish date: July 1, 2012

Not overall, although there is an increased rate of breast cancer in women who began IVF when young, a large cohort study reveals

News

Drospirenone-containing birth control pills may increase risk of blood clots

Author:: Deborah Reale

Publish date: April 1, 2012

News

VTE risk in hormone therapy: Lower with transdermal estradiol than with oral estrogen, study finds

Author:: Deborah Reale

Publish date: October 1, 2011

A large, population-based study found that women who took transdermal estradiol had a 30% lower incidence of venous thromboembolism than those in ...

News

Daughters whose mothers are known carriers of genetic breast cancer are anxious and uninformed

Author:: Deborah Reale

Publish date: October 1, 2011

New breast cancer research unveiled at Era of Hope conference shows young women should be screened starting at age 25

News

FDA WARNING: Unapproved “morning after” contraceptive may be ineffective and unsafe

Author:: Deborah Reale

Publish date: August 1, 2011

Consumers should not use emergency birth control called “Evital”